SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4%
Mon, 1 Feb

SUN PHARMA has announced its results for the quarter ended December 2020. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-19*
3
Sep-20*
3
Dec-20*
QoQ ChangeYoY Change
Net SalesRs m81,54985,53188,3683.3%8.4%
Other incomeRs m1,1992,5583,15023.1%162.7%
TurnoverRs m82,74788,08991,5173.9%10.6%
ExpensesRs m63,13563,59964,3061.1%1.9%
Gross profitRs m18,41421,93324,0619.7%30.7%
DepreciationRs m5,4704,9865,3196.7%-2.8%
InterestRs m630333261-21.6%-58.5%
Profit before taxRs m13,51319,17221,63112.8%60.1%
TaxRs m3,276-3122,449-25.2%
Profit after taxRs m10,23719,48419,181-1.6%87.4%
Gross profit margin%22.625.627.2
Effective tax rate%24.2-1.611.3
Net profit margin%12.422.121.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.4% on a year-on-year (YoY) basis. The expenses were up by 1.9% YoY during the same period.
  • The company's operating profit increased by 30.7% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.2% in 3QFY21 as against 22.6% in 3QFY20.
  • Depreciation charges declined by 2.8% and finance costs declined by 58.5% YoY, respectively.
  • Other income increased by 162.7% YoY during the quarter.
  • Net profit for the quarter increased by 87.4% YoY. Net profit margins during the quarter increased from 12.4% in 3QFY20 to 21.0% in 3QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 3.3% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.1% QoQ during the same period.
  • The company's operating profit increased by 9.7% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.2% in 3QFY21 as against 25.6% in 2QFY20.
  • Net profit for the quarter declined by 1.6% QoQ, while net profit margins declined from 22.1% in 2QFY20 to 21.0% in 3QFY21.

To see how SUN PHARMA has performed over the last eight quarters,please visit here.

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 422.6 to Rs 585.0, registering a Gain of Rs 162.4 or around 38.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 20,585.1 (down 0.2%). Over the last one year it has moved up from 13,734.3 to 20,585.1, a gain of 6,851 points (up 49.9%).

Overall, the S&P BSE SENSEX is up 18.5% over the year.

Current Valuations

At the current price of Rs 585.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 72.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.1 times.